Jul

4

2022

What is the prevalence of antiphospholipid antibodies in patients with systemic lupus erythematosus (SLE)?

By William Aird

A

What is the prevalence of antiphospholipid antibodies in patients with systemic lupus erythematosus (SLE)?

Between 20% and 30% of patients with SLE have persistent moderate-to-high-risk antiphospholipid-antibody profiles that are associated with an increased risk of clinical sequelae.

Learn more here.

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.